Article Details

HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in ...

Retrieved on: 2024-02-25 17:15:33

Tags for this article:

Click the tags to see associated articles and topics

HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in .... View article details on hiswai:

Excerpt

HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up